Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06431152
EARLY_PHASE1

Intra-articular Injection of UC-MSC Exosome in Knee Osteoarthritis

Sponsor: Universidad de los Andes, Chile

View on ClinicalTrials.gov

Summary

The study aim to evaluate safety of exosomes (sEVs) from allogeneic mesenchymal stromal cells delivered by an intra-articular injection in the knee of patients with mild to moderate symptomatic osteoarthritis. The sEVs will be produced in a GMP-facility. The investigators expect to enroll 12 patients in this phase 1 trial open label dose-escalation pilot and the follow-up will be up to 12 months.

Official title: Administration of sEV Derived From UC-MSC in Patients With Osteoarthritis of the Knee: Safety Determination in a Pilot Dose-escalation Study

Key Details

Gender

All

Age Range

30 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2024-06-01

Completion Date

2025-12-31

Last Updated

2024-05-29

Healthy Volunteers

No

Interventions

BIOLOGICAL

UC-MSC sEV

Small extracellular vesicles derived from allogenic mesenchymal stromal cells, single dose

Locations (1)

Clinica Universidad de los Andes

Santiago, Las Condes, Chile